Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Leuk Res
; 30(12): 1589-90, 2006 Dec.
Article
en En
| MEDLINE
| ID: mdl-16542723
ABSTRACT
Autoimmune phenomena are reported to occur frequently in B-cell chronic leukemia (B-CLL). Fludarabine, one of the most effective chemotherapeutic agents for CLL, may increase the risk of these phenomena and may be life-threatening. Here we present a case of an 80-year-old man with B-CLL who developed autoimmune hemolytic anemia (AIHA), associated with one cycle of fludarabine treatment, and who was successfully treated with rituximab and prednisolone.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Vidarabina
/
Leucemia Linfocítica Crónica de Células B
/
Anemia Hemolítica Autoinmune
/
Antineoplásicos
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
Límite:
Aged80
/
Humans
/
Male
Idioma:
En
Revista:
Leuk Res
Año:
2006
Tipo del documento:
Article